Grassley to hold drug pricing hearing

Grassley to hold drug pricing hearing
© Stefani Reynolds

The Senate Finance Committee's first hearing of the year will focus on prescription drug prices, panel chairman Sen. Chuck GrassleyCharles (Chuck) Ernest GrassleyWe've lost sight of the real scandal Grassley: Kavanaugh classmate didn't contact Senate panel State Dept sent explosive-detection dogs to Jordan despite evidence of mistreatment: report MORE (R-Iowa) announced Tuesday.

The Jan. 29 hearing "will be the first in a series of hearings scrutinizing prescription drug pricing and considering policy and oversight solutions to lower costs for American patients," Grassley said in a statement Tuesday.

"We already know what the problem is. It’s time to look at bipartisan solutions and work to turn them into law,” he added.

The Senate hearing will be the same day the Democratic-led House Oversight and Reform Committee holds the first of its own drug pricing hearings.

ADVERTISEMENT

The two hearings on the same day shows the bipartisan nature of the concern over rising drug prices.

Grassley and House Oversight and Reform Committee Chairman Elijah CummingsElijah Eugene CummingsMajority of voters say federal officials staying at Trump hotels is a conflict of interest The Hill's Morning Report - What is Trump's next move on Iran? House committee launches investigation into Transportation Secretary Chao MORE (D-Md.) have made rising drug prices a central concern.

Grassley is largely seen as a dogged investigator who backs free-market principles, and is not seen as an ally of the pharmaceutical industry.

He is also willing to work with Democrats. In September he teamed up with Sen. Dick DurbinRichard (Dick) Joseph DurbinKavanaugh impeachment push hits Capitol buzz saw Democrats seize Senate floor to protest gun inaction: 'Put up or shut up' Pressley on Kavanaugh impeachment: 'Deeply disturbing' that a justice 'could have this many allegations' MORE (D-Ill.) to legislate that television advertisements for drugs be accompanied by price disclosures. The measure was ultimately blocked by House Republicans.

Earlier this month, Grassley laid out his priorities for drug pricing action, including legislation with Sen. Amy KlobucharAmy Jean KlobucharMark Mellman: The most important moment in history? Democrats press for action on election security Antitrust enforcers in turf war over Big Tech MORE (D-Minn.) that would allow patients to import prescription drugs from Canada.

He has also expressed support for much of President TrumpDonald John TrumpJimmy Carter: 'I hope there's an age limit' on presidency White House fires DHS general counsel: report Trump to cap California trip with visit to the border MORE's drug pricing agenda.